在阿尔茨海默病中探索非编码RNA的治疗潜力
Siddhant Tripathi1, Yashika Sharma1, Dileep Kumar2
1Department of Pharm. Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, 411038, India.
Protein and peptide letters
|November 19, 2024
概括
非编码RNAs (ncRNAs) 在阿尔茨海默病 (AD) 研究中表现有前途. 针对这些分子,如microRNAs,可能会为AD提供新的治疗策略和早期诊断生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,没有有效的治疗方法.
- 关键的病理特征包括粉样β (Aβ) 斑块,高酸化Tau和神经炎症.
- 导致AD病变的精确分子机制尚未完全理解.
研究的目的:
- 审查非编码RNAs (ncRNAs) 在阿尔茨海默病中的作用.
- 探索ncRNAs作为潜在的生物标志物和AD的治疗点.
- 检查ncRNAs和AD途径之间的转录后调节关系.
主要方法:
- 对阿尔茨海默病中ncRNAs研究的文献综述.
- 在AD中分析微RNA (miRNA),长非编码RNA (lncRNA) 和圆形RNA (circRNA) 调节基因表达的分析.
- 研究特定的miRNA角色,如miR-346和miR-107,在Aβ生产中的作用.
主要成果:
- 在AD中,ncRNAs在调节基因表达方面发挥着重要作用.
- 特定的miRNAs,如miR-346和miR-107,通过分别准APP mRNA和BACE1,影响粉样β (Aβ) 生产.
- ncRNAs在脑脊液 (CSF) 和血液中显示出作为稳定的生物标志物的潜力,用于早期AD检测.
结论:
- ncRNAs,特别是miRNAs,与AD病原和进展有关.
- 准ncRNAs为新型阿尔茨海默病治疗提供了一个有希望的途径.
- 需要进一步的研究来阐明RNA片段在AD蛋白沉积中的作用,并充分利用ncRNAs用于AD治疗和诊断.
相关概念视频
02:30siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:20Types of RNA
5.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.7K
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
01:26Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K